CI
TECH icon

Capital International’s Bio-Techne TECH Stock Holding History

Capital International’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,181
Closed -$217K – 156
2023
Q3 		$217K Sell
3,181
-461
-13% -$36.4K 0.01% 154
2023
Q2 		$297K Hold
3,642
– – 0.02% 159
2023
Q1 		$270K Buy
+3,642
New +$281K 0.02% 160

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Capital International's TECH Position: Q4 2023 in Review

Capital International sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 3,181 shares — an estimated $217K sold.

Capital International first reported a position in TECH in Q1 2023 and held it in 3 quarters. The position peaked at $297K in Q2 2023. 530 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

  • Capital International reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
  • Capital International sold 3,181 Bio-Techne shares in Q4 2023, an estimated $217K.
  • Capital International first reported a position in Bio-Techne in Q1 2023 and held it in 3 quarters.
  • Capital International's Bio-Techne position peaked at $297K in Q2 2023.
  • 530 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Capital International's 13F filing for Q4 2023, filed 13 Feb 2024.